fda glp-1 compounding enforcement news Report: must enforce rules on compounded GLP-1s π¨ FDA Cracks Down on
Description
Ulie, C
, GLP-1 secretion is not altered v
These medications should generally be avoided in patients with a history of pancreatitis
Public awareness of GLP-1 therapies continues to grow, particularly because of weight management benefits, which may increase patient interest in these medications
doi:10.1155/2018/1205121
